1 / 9

Nonalcoholic Steatohepatitis (NASH) Market by Therapeutics | 2020

NASH Market is expected to garner $1.6 billion by 2020, registering a CAGR of 25.6% during the forecast period 2014-2020. Increase in cycles of clinical trials and their success rate has increased the probability of industries receiving commercial approval for NASH therapeutics by the end of 2017.

Abhi711
Download Presentation

Nonalcoholic Steatohepatitis (NASH) Market by Therapeutics | 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nonalcoholic Steatohepatitis (NASH) Market Opportunity Analysis and Industry Forecast, 2016-2023 Global Opportunity Analysis and Industry Forecast, 2017-2023

  2. Introductionof Nonalcoholic Steatohepatitis (NASH) Market The global market is expected to garner $1.6 billion by 2020, registering a CAGR of 25.6% during the period 2014-2020. The high prevalence of Type II diabetes and obesity, which lead to NASH and other nonalcoholic fatty liver diseases (NAFLD), would boost market growth. North America's heightened focus of NASH research has resulted in its accounting for nearly half of the global market. It is also the region with the maximum occurrences of NASH and other nonalcoholic fatty liver diseases. Europe ranks second in terms of the prevalence of NASH. The number of patients living with the diabetes worldwide is expected to soar from 371 million in 2012 to 552 million by 2030. This suggests that by 2030, there will be 3 new cases of diabetes every 10 seconds. "The rampant growth of diabetes and obesity has prompted pharmaceutical manufacturers to seek out novel pharmaceutical solutions to tap promising potential in NASH," states AMR analyst Roshan Deshmukh. "Instrumental initiatives and increasing clinical trials for the development of novel NASH therapeutics will steer its faster commercialization," adds the analyst.

  3. Introductionof Nonalcoholic Steatohepatitis (NASH) Market Scopeof theReport KeyBenefits KeyAudiences

  4. Key Benefits Various opportunities for non alcoholic fatty liver disease therapeutics present in developed as well as developing economies are thoroughly assessed. Substitute treatments and their potential impact on NASH therapeutics are strategically quantified in the report. Opportunities from a business perspective latent in the Asia-Pacific region are brought to light. Market dimensions of diagnostic techniques used in NASH monitoring provide a clear outline of the NASH therapeutics research market Geography-wise segmentation of clinical trials is conducted to provide strategic intelligence to the stakeholder. Drivers and factors limiting market expansion are studied in detail. Click to Access Full Summary of Non-alcoholic Steatohepatitis Market

  5. Table of Content (TOC) Chapter 1: Introduction Chapter 2: Executive Summary Chapter 3: Market Overview Chapter 4: Market Beyond: What To Expect By 2025 Chapter 5: Global Nonalcoholic Steatohepatitis Market By Drug Types Chapter 6: Global Nonalcoholic Steatohepatitis Market (Pipeline Drug Analysis)by Geography, 2013-2020 Chapter 8. Company Profiles

  6. Segments Nonalcoholic Steatohepatitis (NASH) Market

  7. Segments Nonalcoholic Steatohepatitis (NASH) Market

  8. Company Profiles Ceramic Matrix Composites Market 1. Genfit 2. Gilead Science 3. Novo Nordisk 4. Intercepts Pharmaceuticals 5. Enzo Biochem, Inc. 6. Raptor Pharmaceutical Corp.

  9. Thank You Ceramic Matrix Composites Market ThankYou! For MoreDetails Do Enquiry https://www.alliedmarketresearch.com/nonalcoholic-steatohepatitis-NASH-market Follow UsOn

More Related